Authors: Eilber, FC Rosen, G Eckardt, J Forscher, C Nelson, SD Selch, M Dorey, F Eilber, FR

Citation: Fc. Eilber et al., Treatment-induced pathologic necrosis: A predictor of local recurrence andsurvival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas, J CL ONCOL, 19(13), 2001, pp. 3203-3209

Authors: Georgoulias, V Scagliotti, G Miller, V Eckardt, J Douillard, JY Manegold, C

Citation: V. Georgoulias et al., Challenging the platinum combinations: Docetaxel (Taxotere) combined with gemcitabine or vinorelbine in non-small cell lung cancer, SEMIN ONCOL, 28(1), 2001, pp. 15-21

Authors: Fields-Jones, S Koletsky, A Wilding, G O'Rourke, M O'Rourke, T Eckardt, J Yates, B McGuirt, C Burris, HA

Citation: S. Fields-jones et al., Improvements in clinical benefit with vinorelbine in the treatment of hormone-refractory prostate cancer: A phase II trial, ANN ONCOL, 10(11), 1999, pp. 1307-1310

Authors: DeVore, RF Johnson, DH Crawford, J Garst, J Dimery, IW Eckardt, J Eckhardt, SG Elfring, GL Schaaf, LJ Hanover, CK Miller, LL

Citation: Rf. Devore et al., Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer, J CL ONCOL, 17(9), 1999, pp. 2710-2720